Shanghai Haini Pharmaceutical Co. Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private, Subsidiary
- Established
- 2001-01-08
- Employees
- -
- Market Cap
- -
- Website
- http://www.ehaini.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers
Phase 1
Completed
- Conditions
- Bioequivalence
- Interventions
- Drug: LANDI-Amlodipine Besylate Tablet 5mg
- First Posted Date
- 2016-11-28
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Shanghai Haini Pharmaceutical Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02974439
- Locations
- 🇨🇳
Shanghai Haini Pharmaceutical Co., Ltd., Shanghai, China
News
No news found